First mRNA-Based COVID 19 Vaccine Gets Nod for Phase II/III Trial
The fight against the ongoing epidemic of COVID-19 is all set to get stronger. The office of the Drug Controller General of India has approved a proposal of the Pune-based Gennova Biopharmaceuticals Ltd., to go in for phase II / III trial…
Read More...
Read More...